Some more info on this combination study. I especially like...

Some more info on this combination study. I especially like Vactoserib's use in combination with our NK-Cells to overcome the TME Tumor micro environment “Vactosertib has never been used in combination with NK cells in the clinic, but it has been used in humans in other clinical trials,” she says. “The goal of using it in this trial is to disrupt the TGF-β signaling pathway that is so strong in colorectal cancer and cells.We want to shut down that TGF-β signaling pathway so that the NK cells can actually make it into the tumors. Once they’re there, they have a chance or being active instead of just being silenced right away.” More newsflow lined up with our huge pipeline. It's going to be non stop as the various stages of each indication progresses.